A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy

Combination therapy with ipilimumab and nivolumab immunotherapy may be effective in the treatment of aggressive intraocular metastatic cutaneous melanoma.

Authors

Institutions

Publication Details

Journal
BMC Ophthalmology
Published
2025-01-09
DOI
https://doi.org/10.1186/s12886-025-03847-w
Citations
2
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
3.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy

Matthew W. Wilson, William I. Evans, Ansam I. Qaddoumi
2 citations
BMC Ophthalmology
Ocular Oncology and Treatments
3.41
article

A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy

Matthew W. Wilson, William I. Evans, Ansam I. Qaddoumi
article en
2 citations

Abstract

Combination therapy with ipilimumab and nivolumab immunotherapy may be effective in the treatment of aggressive intraocular metastatic cutaneous melanoma.

BMC OphthalmologyVol. 25(1)
East Tennessee State University (US), St. Jude Children's Research Hospital (US), University of Tennessee Health Science Center (US), University of Tennessee at Knoxville (US)
Good health and well-being
Openalex Percentile: Top 11%
Ocular Oncology and Treatments
3.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.